The board of directors of Sun Pharma approved the appointment of Goenka and Bijapurkar as additional independent directors on the board of the company, with effect from May 21, 2021, to hold office up to the ensuing 29th annual general meeting of the company, Sun Pharma said in a regulatory filing.